The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
Open accessAbstract
Gamma interferon (IFN gamma) is a potent immune mediator that plays a central role in enhancing cellular immune processes. This study demonstrates that while lung mononuclear cells from normal individuals spontaneously release little or no interferon (less than 10 U/10(6) cells per 24 h), those from patients with pulmonary sarcoidosis spontaneously release considerable amounts (65 +/- 20 U/10(6) cells per 24 h, P less than 0.02 compared to normals). Furthermore, cells from patients with active disease release far more interferon than those from patients with inactive disease (101 +/- 36 compared to 24 +/- 8 U/10(6) cells per 24 h, P less than 0.02). Characterization of this interferon using acid sensitivity, specific antibody inhibition, and target cell specificity criteria demonstrated that it was almost entirely IFN gamma. This spontaneous release of IFN gamma appeared to be compartmentalized to the lung of these patients in that their blood mononuclear cells spontaneously released little or no IFN gamma (P less than 0.02, compared to sarcoidosis lung mononuclear cells) and no IFN gamma was detected in their serum. Both lung T lymphocytes and alveolar macrophages contributed to the spontaneous release of IFN gamma by lung mononuclear cells from sarcoid patients; purified preparations of T lymphocytes and alveolar macrophages from these patients spontaneously released similar amounts of IFN gamma (56 +/- 21 and 32 +/- 11 U/10(6) cells per 24 h, respectively, P greater than 0.3). At least one role for IFN gamma in the pathogenesis of sarcoidosis appeared to be related to activation of alveolar macrophages, as alveolar macrophages recovered from patients with active disease spontaneously killed [3H]uridine-labeled tumor cell targets (17.7 +/- 4.5% cytotoxicity compared with 2.8 +/- 0.9% in normals, P less than 0.02) and purified IFN gamma enhanced the ability of alveolar macrophages from sarcoidosis patients with inactive disease to kill similar targets (P less than 0.001, compared to alveolar macrophages cultured in medium alone). Treatment of sarcoid patients with corticosteroids, a therapy known to suppress the activity of the disease, caused a marked reduction in the level of spontaneous IFN gamma release by lung mononuclear cells compared with untreated patients (P less than 0.02), which suggests that the effectiveness of corticosteroid therapy in controlling active pulmonary sarcoidosis may, at least in part, be due to suppression of IFN gamma release.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stewart, W. E. (1979) · Springer eBooks · doi:10.1007/978-3-7091-3432-0 · Cited by 1,158
Spagnolo, P., Rossi, G., Trisolini, R., Sverzellati, N., Baughman, R. P., & Wells, A. U. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30064-x · Cited by 949
Hunninghake, G. W., Gadek, J. E., Kawanami, O., Ferrans, V. J., & Crystal, R. G. (1979) · PubMed Central · Cited by 941
Self-citationCrystal, R. G., Bitterman, P. B., Rennard, S. I., Hance, A. J., & Keogh, B. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198401193100304 · Cited by 690
Self-citationHunninghake, G. W., & Crystal, R. G. (1981) · New England Journal of Medicine · doi:10.1056/nejm198108203050804 · Cited by 689
Self-citationRecombinant interferon-gamma increases HLA-DR synthesis and expression.
Basham, T. Y., & Merigan, T. C. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.4.1492 · Cited by 575
Murray, H. W., Rubin, B. Y., Masur, H., & Roberts, R. B. (1984) · New England Journal of Medicine · doi:10.1056/nejm198404053101404 · Cited by 513
Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.
Kasahara, T., Hooks, J. J., Dougherty, S. F., & Oppenheim, J. J. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.4.1784 · Cited by 479
Crystal, R. G., Bitterman, P. B., Rennard, S. I., Hance, A. J., & Keogh, B. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198401263100406 · Cited by 463
Self-citationPulmonary Sarcoidosis: A Disease Characterized and Perpetuated by Activated Lung T-Lymphocytes
CRYSTAL, R. G., ROBERTS, W. C., HUNNINGHAKE, G. W., GADEK, J. E., FULMER, J. D., & LINE, B. R. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-1-73 · Cited by 418
Self-citation
Cited by
Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma
Robinson, D. S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A. M., Corrigan, C., Durham, S. R., & Kay, A. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260504 · Cited by 2,768
Secretory products of macrophages.
Nathan, C. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112815 · Cited by 2,615
(1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.ats4-99 · Cited by 1,902
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
Lucey, D. R., Clerici, M., & Shearer, G. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.532 · Cited by 666
Baughman, R. P., Lower, E. E., & du Bois, R. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12888-7 · Cited by 657
Gerdes, N., Sukhova, G. K., Libby, P., Reynolds, R. S., Young, J. L., & Schönbeck, U. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011022 · Cited by 506
JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis ― Digest Version ―
Terasaki, F., Azuma, A., Anzai, T., Ishizaka, N., Ishida, Y., Isobe, M., Inomata, T., Ishibashi-Ueda, H., Eishi, Y., Kitakaze, M., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0508 · Cited by 479
IFN-γ production by antigen-presenting cells: mechanisms emerge
Frucht, D. M., Fukao, T., Bogdan, C., Schindler, H., O'Shea, J. J., & Koyasu, S. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02005-1 · Cited by 461
Interferon-Gamma, the Activated Macrophage, and Host Defense Against Microbial Challenge
MURRAY, H. W. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-4-595 · Cited by 422
High IFN-γ and low SLPI mark severe asthma in mice and humans
Raundhal, M., Morse, C., Khare, A., Oriss, T. B., Milosevic, J., Trudeau, J., Huff, R., Pilewski, J., Holguin, F., Kolls, J., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80911 · Cited by 393
Neopterin as Marker for Activation of Cellular Immunity: Immunologic Basis and Clinical Application
(1989) · Advances in Clinical Chemistry · doi:10.1016/s0065-2423(08)60182-1 · Cited by 373
Song, Z., Marzilli, L., Greenlee, B. M., Chen, E. S., Silver, R. F., Askin, F. B., Teirstein, A. S., Zhang, Y., Cotter, R. J., & Moller, D. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040429 · Cited by 372
Sarcoidosis: Clinical Presentation, Immunopathogenesis, and Therapeutics
Iannuzzi, M. C. (2011) · JAMA · doi:10.1001/jama.2011.10 · Cited by 338
IFN-γ Induces High Mobility Group Box 1 Protein Release Partly Through a TNF-Dependent Mechanism
Rendon-Mitchell, B., Ochani, M., Li, J., Han, J., Wang, H., Yang, H., Susarla, S., Czura, C., Mitchell, R. A., Chen, G., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3890 · Cited by 337
Ying, S., Durham, S. R., Corrigan, C. J., Hamid, Q., & Kay, A. B. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.12.5.7742012 · Cited by 335
Macrophage-derived angiogenesis factors
Sunderkötter, C., Goebeler, M., Schulze-Osthoff, K., Bhardwaj, R., & Sorg, C. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90077-y · Cited by 332
Dual role of macrophages in tumor growth and angiogenesis
Lamagna, C., Aurrand-Lions, M., & Imhof, B. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105656 · Cited by 311
Murayama, A., Takeyama, K.-I., Kitanaka, S., Kodera, Y., Kawaguchi, Y., Hosoya, T., & Kato, S. (1999) · Endocrinology · doi:10.1210/endo.140.5.6691 · Cited by 298
Wong, H. L., & Wahl, S. M. (1990) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-74781-6_18 · Cited by 295
Seymour, J., & Gagel, R. (1993) · Blood · doi:10.1182/blood.v82.5.1383.1383 · Cited by 291
(1990) · European Respiratory Journal · doi:10.1183/09031936.93.03080937 · Cited by 290
Cytokine Networks in the Regulation of Inflammation and Fibrosis in the Lung
Elias, J. A., Freundlich, B., Kern, J. A., & Rosenbloom, J. (1990) · Chest · doi:10.1378/chest.97.6.1439 · Cited by 262
Ramstein, J., Broos, C. E., Simpson, L. J., Ansel, K. M., Sun, S. A., Ho, M. E., Woodruff, P. G., Bhakta, N. R., Christian, L., Nguyen, C. P., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201507-1499oc · Cited by 260
Cembrzynska-Nowak, M., Szklarz, E., Inglot, A. D., & Teodorczyk-Injeyan, J. A. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.2.291 · Cited by 260
Bitterman, P. B., Wewers, M. D., Rennard, S. I., Adelberg, S., & Crystal, R. G. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112364 · Cited by 232
Self-citationEndogenous interferon-γ is required for efficient skeletal muscle regeneration
Cheng, M., Nguyen, M.-H., Fantuzzi, G., & Koh, T. J. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00568.2007 · Cited by 214
Yu, J. L., & Rak, J. W. (2003) · Breast Cancer Research · doi:10.1186/bcr573 · Cited by 146
Whittington (2004) · doi:10.1165/rcmb.2003-0285oc · Cited by 130
In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases
PRIOR, C., & HASLAM, P. L. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb03074.x · Cited by 118
Daoud, A., Lema, D. A., Won, T., & Čiháková, D. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1227818 · Cited by 10
Metadata
- Authors
- Robinson, B. W., McLemore, T. L., & Crystal, R. G.
- Venue
- Journal of Clinical Investigation
- Published
- 1985-05-01
- Volume
- 75
- Issue
- 5
- Pages
- 1488-1495
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2117206496
- Cited by
- 458
- References
- 32
- FWCI
- 20.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.